_advancing-regulatory-science-in-europe-preview-1.jpg "Advancing regulatory science in Europe from www ema europa eu xarelto Video Screenshot Preview 1")
Gallery_advancing-regulatory-science-in-europe-preview-3.jpg "Advancing regulatory science in Europe from www ema europa eu xarelto Video Screenshot Preview 3")
Gallery_advancing-regulatory-science-in-europe-preview-hqdefault.jpg "Advancing regulatory science in Europe from www ema europa eu xarelto Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 32 seconds
👁 View: 495 times
Play Audio:👁 View: 495 times
Description:
European Medicines Agency
European Medicines Agency
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_esc-tv-at-acc-17-gemini-acs-1-low-dose-rivaroxaban-vs-aspirin.webp "European Society of Cardiology")
_the-importance-of-the-european-medicines-agency-in-car-t-development.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_the-european-medicines-agency-and-patient-involvement-in-the-drug-approval-process.webp "Lung Cancer Europe")
⏲ 57 minutes 19 seconds 👁 255
_cost-analysis-rivaroxaban-vs-warfarin.webp "CSWNews")
_esc-tv-at-heart-failure-2018-rivaroxaban-plus-aspirin-in-patients-with-and-without-heart-failure.webp "European Society of Cardiology")
⏲ 3 minutes 10 seconds 👁 2.1K
_esc-tv-at-acc-17-gemini-acs-1-low-dose-rivaroxaban-vs-aspirin.jpg)
_the-importance-of-the-european-medicines-agency-in-car-t-development.jpg)
_the-european-medicines-agency-and-patient-involvement-in-the-drug-approval-process.jpg)
_cost-analysis-rivaroxaban-vs-warfarin.jpg)
_esc-tv-at-heart-failure-2018-rivaroxaban-plus-aspirin-in-patients-with-and-without-heart-failure.jpg)
![[+]](/images/menu.gif){kind=small}